Crossmark

Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations

Crossref DOI link: https://doi.org/10.1186/s12964-023-01139-8

Published Online: 2023-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Leilei

Zhang, Zhenshan

Bai, Menglin

Yan, Yujie

Yu, Jinming

Xu, Yaping
License Information

Text and Data Mining valid from 2023-05-23

Version of Record valid from 2023-05-23
More Information

Article History

Received: 21 January 2023

Accepted: 22 April 2023

First Online: 23 May 2023

Declarations

:

: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by Ethics Committee of Shanghai Pulmonary Hospital. Written informed consent was taken from all the patients.

: All authors have no conflicts of interest to declare. The figures were created with the help of BioRender.com.

Document is current

Any future updates will be listed below